background image

Clinical Trials In Orlando

Discover hundreds of clinical trials in Orlando.
Search clinical trials in Orlando by condition or phase.

e.g. Respiratory Diseases
OrlandoHealthy volunteers: No

A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.

Recruiting
PHASE3

Sponsor:

AbbVie

Location:

Orlando, Orange City, Tampa, Tamaracshow 42 more

Code:

NCT04777357

Conditions

Depression

Bipolar I Disorder

Eligibility Criteria

Sex: All

Age: 10 - 17

Healthy Volunteers: Not accepted

Interventions

Cariprazine

Placebo

A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma

Recruiting
PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Orlando, Saint Petersburg, Gainesville, Jacksonvilleshow 99 more

Code:

NCT03871257

Conditions

Low Grade Glioma

Neurofibromatosis Type 1

Visual Pathway Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Selumetinib Sulfate

Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.

Recruiting
PHASE3

Sponsor:

Amneal Pharmaceuticals, LLC

Location:

New Smyrna Beach, Morrow, Roswell, Nashvilleshow 5 more

Code:

NCT05401357

Conditions

Glaucoma, Open-Angle

Ocular Hypertension

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Test - Bimatoprost 0.01% Ophthalmic Solution

Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)

Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Recruiting

Sponsor:

Novartis Pharmaceuticals

Location:

Orlando, Fort Myers, Miami, Palmetto Bayshow 44 more

Code:

NCT04174157

Conditions

Spinal Muscular Atrophy (SMA)

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Prospective observational registry

Zolgensma

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

Recruiting
PHASE3

Sponsor:

GlaxoSmithKline

Location:

Winter Park, Clearwater, Plantation, Aventurashow 35 more

Code:

NCT06261957

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Salbutamol HFA-134a

Salbutamol HFA-152a

Evaluation of the Clinical Utility of Endoscopic Closure Using a Dual Action Tissue (DAT) Clip

Recruiting

Sponsor:

AdventHealth

Location:

Orlando, Fort Wayne

Code:

NCT05852457

Conditions

GI Bleeding

Perforation Colon

Perforation Bowel

Perforation Duodenal

Perforated Bowel

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DAT Clip

A Study with NKT3964 for Adults with Advanced/Metastatic Solid Tumors

Recruiting
PHASE1

Sponsor:

NiKang Therapeutics, Inc.

Location:

Lake Mary, Nashville, Hackensack

Code:

NCT06586957

Conditions

Solid Tumor

Advanced Solid Tumor

Solid Tumor, Adult

Metastatic Tumor

Ovarian Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NKT3964

A Study to Describe the Characteristics, Health Care Interventions and Outcomes of Patients With Major Bleedings in the Presence of Factor Xa Inhibitor Treatment

Recruiting

Sponsor:

AstraZeneca

Location:

Orlando, Chapel Hill, Lexington, Columbusshow 16 more

Code:

NCT06147830

Conditions

Major Bleeding

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

None (Observational study)

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

Recruiting
PHASE3

Sponsor:

SWOG Cancer Research Network

Location:

Orlando, Jacksonville, Deerfield Beach, Plantationshow 238 more

Code:

NCT03678025

Conditions

Castration Levels of Testosterone

Metastatic Prostatic Adenocarcinoma

Stage IV Prostate Cancer AJCC v8

Stage IVA Prostate Cancer AJCC v8

Stage IVB Prostate Cancer AJCC v8

Eligibility Criteria

Sex: Male

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abiraterone

Bicalutamide

Degarelix

Docetaxel

Flutamide

Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)

Recruiting
PHASE1
PHASE2

Sponsor:

Prevail Therapeutics

Location:

Orlando, Maitland, Philadelphia

Code:

NCT04408625

Conditions

Frontotemporal Dementia

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

LY3884963

Methylprednisolone

Optional Sirolimus

Optional Prednisone

Orlando, Florida has a well-developed healthcare system with several prominent medical research facilities, making it an important hub for a diverse array of clinical trials. Notable institutions such as the Orlando Health Cancer Institute and the University of Central Florida's College of Medicine are at the forefront of these research initiatives.

Each medical center in Orlando focuses on innovative studies across various fields, including oncology, cardiovascular health, and neurological disorders, positioning Orlando as a vital contributor in advancing medical research and treatment options.

Why choose Orlando for clinical trials?

Common conditions studied in Orlando

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Orlando